Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 793879, 9 pages
http://dx.doi.org/10.1155/2014/793879
Research Article

Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10

1State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
2State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Life Sciences, Tsinghua University, Beijing 100084, China
3Jiangsu Longliqi Bioscience Co., Ltd., Suzhou 215555, China

Received 4 March 2014; Revised 23 May 2014; Accepted 23 May 2014; Published 5 June 2014

Academic Editor: René Holm

Copyright © 2014 Huafeng Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Choi, H.-H. Park, S.-H. Koh et al., “Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway,” NeuroToxicology, vol. 33, no. 1, pp. 85–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sacconi, E. Trevisson, L. Salviati et al., “Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy,” Neuromuscular Disorders, vol. 20, no. 1, pp. 44–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Schmelzer and F. Döring, “Micronutrient special issue: coenzyme Q10 requirements for DNA damage prevention,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 733, no. 1-2, pp. 61–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Singh, S. Devaraj, and I. Jialal, “Coenzyme Q10 supplementation and heart failure,” Nutrition Reviews, vol. 65, no. 6, pp. 286–293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Mancuso, D. Orsucci, L. Volpi, V. Calsolaro, and G. Siciliano, “Coenzyme Q10 in neuromuscular and neurodegenerative disorders,” Current Drug Targets, vol. 11, no. 1, pp. 111–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Salles, V. A. Moisés, D. R. Almeida, A. R. Chacra, and R. S. Moisés, “Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10,” Diabetes Research and Clinical Practice, vol. 72, no. 1, pp. 100–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Marcoff and P. D. Thompson, “The role of coenzyme Q10 in statin-associated myopathy: a systematic review,” Journal of the American College of Cardiology, vol. 49, no. 23, pp. 2231–2237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Bank, D. Kagan, and D. Madhavi, “Coenzyme Q10: clinical update and bioavailability,” Journal of Evidence-Based Complementary and Alternative Medicine, vol. 16, no. 1, pp. 129–137, 2011. View at Google Scholar · View at Scopus
  9. T. R. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, “Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment,” International Journal of Pharmaceutics, vol. 212, no. 2, pp. 233–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Stratulat, M. Britten, S. Salmieri et al., “Encapsulation of coenzyme Q10 in a simple emulsion-based nutraceutical formulation and application in cheese manufacturing,” Food Chemistry, vol. 141, no. 3, pp. 2707–2712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Ullmann, J. Metzner, C. Schulz, J. Perkins, B. Leuenberger, and R. Corcovic, “A new coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB,” Journal of Medicinal Food, vol. 8, no. 3, pp. 397–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Thanatuksorn, K. Kawai, M. Hayakawa, M. Hayashi, and K. Kajiwara, “Improvement of the oral bioavailability of coenzyme Q10 by emulsification with fats and emulsifiers used in the food industry,” Food Science and Technology, vol. 42, no. 1, pp. 385–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. R. Nepal, H.-K. Han, and H.-K. Choi, “Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation,” International Journal of Pharmaceutics, vol. 383, no. 1-2, pp. 147–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Balakrishnan, B.-J. Lee, D. H. Oh et al., “Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems,” International Journal of Pharmaceutics, vol. 374, no. 1-2, pp. 66–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Belhaj, F. Dupuis, E. Arab-Tehrany et al., “Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA's nanoemulsions,” European Journal of Pharmaceutical Sciences, vol. 47, no. 2, pp. 305–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Zhou, J. Zhang, Y. Long, G. Liu, M. Duan, and Q. Xia, “Improvement of the oral bioavailability of coenzyme Q10 with lecithin nanocapsules,” Journal of Nanoscience and Nanotechnology, vol. 13, no. 1, pp. 706–710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. H. Porter, N. L. Trevaskis, and W. N. Charman, “Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs,” Nature Reviews Drug Discovery, vol. 6, no. 3, pp. 231–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh, “Lipid: an emerging platform for oral delivery of drugs with poor bioavailability,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 1, pp. 1–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S.-F. Han, T.-T. Yao, X.-X. Zhang et al., “Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation,” International Journal of Pharmaceutics, vol. 379, no. 1-2, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Balakrishnan, B.-J. Lee, D. H. Oh et al., “Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS),” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 3, pp. 539–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. S. Nielsen, K. B. Petersen, and A. Müllertz, “Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 2, pp. 553–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. J. H. Porter and W. N. Charman, “In vitro assessment of oral lipid based formulations,” Advanced Drug Delivery Reviews, vol. 50, no. 1, pp. S127–S147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. C. W. Pouton, “Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems,” European Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. S93–S98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Dahan and A. Hoffman, “Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs,” Journal of Controlled Release, vol. 129, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Zhou, J. Zhang, Q. Jin et al., “Targeting of coenzyme Q10 via d-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanoemulsion to the heart,” Materials Letters, vol. 109, pp. 20–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Ostertag, J. Weiss, and D. J. McClements, “Low-energy formation of edible nanoemulsions: factors influencing droplet size produced by emulsion phase inversion,” Journal of Colloid and Interface Science, vol. 388, no. 1, pp. 95–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Acosta, “Bioavailability of nanoparticles in nutrient and nutraceutical delivery,” Current Opinion in Colloid and Interface Science, vol. 14, no. 1, pp. 3–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Wajda, J. Zirkel, and T. Schaffer, “Increase of bioavailability of coenzyme Q10 and vitamin E,” Journal of Medicinal Food, vol. 10, no. 4, pp. 731–734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Klang, N. B. Matsko, C. Valenta, and F. Hofer, “Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment,” Micron, vol. 43, no. 2-3, pp. 85–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Mayer, J. Weiss, and D. J. McClements, “Vitamin E-enriched nanoemulsions formed by emulsion phase inversion: factors influencing droplet size and stability,” Journal of Colloid and Interface Science, vol. 402, pp. 122–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. E. D. Manev and R. J. Pugh, “Diffuse layer electrostatic potential and stability of thin aqueous films containing a nonionic surfactant,” Langmuir, vol. 7, no. 10, pp. 2253–2260, 1991. View at Google Scholar · View at Scopus
  32. S. Stolnik, S. E. Dunn, M. C. Garnett et al., “Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers,” Pharmaceutical Research, vol. 11, no. 12, pp. 1800–1808, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Saupe, K. C. Gordon, and T. Rades, “Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy,” International Journal of Pharmaceutics, vol. 314, no. 1, pp. 56–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Spernath, O. Regev, Y. Levi-Kalisman, and S. Magdassi, “Phase transitions in O/W lauryl acrylate emulsions during phase inversion, studied by light microscopy and cryo-TEM,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 332, no. 1, pp. 19–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. A. Wissing, R. H. Müller, L. Manthei, and C. Mayer, “Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy,” Pharmaceutical Research, vol. 21, no. 3, pp. 400–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Kuntsche, M. H. J. Koch, A. Fahr, and H. Bunjes, “Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity,” European Journal of Pharmaceutical Sciences, vol. 38, no. 3, pp. 238–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Delie, “Evaluation of nano- and microparticle uptake by the gastrointestinal tract,” Advanced Drug Delivery Reviews, vol. 34, no. 2-3, pp. 221–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Yin Win and S.-S. Feng, “Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs,” Biomaterials, vol. 26, no. 15, pp. 2713–2722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Y. Koroleva and E. V. Yurtov, “Nanoemulsions: the properties, methods of preparation and promising applications,” Russian Chemical Reviews, vol. 81, no. 1, pp. 21–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Kotta, A. W. Khan, K. Pramod, S. H. Ansari, R. K. Sharma, and J. Ali, “Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs,” Expert Opinion on Drug Delivery, vol. 9, no. 5, pp. 585–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Belhaj, F. Dupuis, E. Arab-Tehrany et al., “Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA's nanoemulsions,” European Journal of Pharmaceutical Sciences, vol. 47, no. 2, pp. 305–312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. V. Miles, “The uptake and distribution of coenzyme Q(10),” Mitochondrion, vol. 7, pp. S72–S77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. N. L. Trevaskis, W. N. Charman, and C. J. H. Porter, “Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 702–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Cornaire, J. Woodley, P. Hermann, A. Cloarec, C. Arellano, and G. Houin, “Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo,” International Journal of Pharmaceutics, vol. 278, no. 1, pp. 119–131, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. E. V. Batrakova, S. Li, Y. Li, V. Y. Alakhov, and A. V. Kabanov, “Effect of pluronic P85 on ATPase activity of drug efflux transporters,” Pharmaceutical Research, vol. 21, no. 12, pp. 2226–2233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-Y. Chiu, K. Higaki, B. L. Neudeck, J. L. Barnett, L. S. Welage, and G. L. Amidon, “Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells,” Pharmaceutical Research, vol. 20, no. 5, pp. 749–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Simon and R. Schubert, “Inhibitory effect of phospholipids on P-glycoprotein: cellular studies in Caco-2, MDCKII mdr1 and MDCKII wildtype cells and P-gp ATPase activity measurements,” Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, vol. 1821, no. 9, pp. 1211–1223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Shono, H. Nishihara, Y. Matsuda et al., “Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes,” Journal of Pharmaceutical Sciences, vol. 93, no. 4, pp. 877–885, 2004. View at Publisher · View at Google Scholar · View at Scopus